Latest market price
114.32
-2.58-2.21%
HNGEQT73Hinge Health, Inc.·NYSE
114.32-2.21%
TA
Loading chart...
Signal & projected range
Gap down — mean-reversionHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index—P/E88.62EPS (ttm)1.29Insider Own—Shs Outstand80.69MPerf Week2.51%
Market Cap9.22BForward P/E39.07EPS next Y2.93Insider Trans-7.70%Shs Float76.51MPerf Month16.72%
Enterprise Value8.84BPEG3.87EPS next Q0.57Short Float8.25%Perf Quarter47.22%
Income109.00MP/S12.81EPS this Y59.85%Short Ratio3.50Perf Half Y151.64%
Sales720.00MP/B26.82EPS next Y26.16%ROA13.18%Short Interest6.31MPerf YTD146.11%
Book/sh4.26P/C23.71EPS next 5Y22.89%ROE30.25%52W High117.55 -2.75%Perf Year130.48%
Cash/sh4.82P/FCF32.14EPS past 3/5Y—ROIC26.29%52W Low30.08 280.05%Perf 3Y—
Dividend Est.—EV/EBITDA85.81Sales past 3/5Y—Gross Margin84.52%Volatility3.26% 3.92%Perf 5Y—
Dividend TTM—EV/Sales12.27EPS Y/Y TTM—Oper. Margin13.01%ATR (14)4.29Perf 10Y—
Dividend Ex-Date—Quick Ratio1.30Sales Y/Y TTM49.69%Profit Margin15.15%RSI (14)67.50Recom2.06
Dividend Gr. 3/5Y—Current Ratio1.34EPS Q/Q-11.94%SMA207.26%Beta1.10Target Price103.92
Payout0.00%Debt/Eq0.01Sales Q/Q53.24%SMA5016.45%Rel Volume1.51Prev Close116.90
Employees1,437LT Debt/Eq0.01EarningsNov 02SMA20070.48%Avg Volume1.91MPrice114.32
IPO DateMay 22, 2025Option/ShortYes / YesEPS/Sales Surpr.-4.07% 5.64%Net Debt/EBITDA-3.76Volume2,878,602Change-2.21%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-26-26ReiteratedStifel Nicolaus$115 → $130
Oct-16-26ReiteratedKeybancOverweight$125 → $140
Oct-12-26ReiteratedBarclaysOverweight$100 → $110
Sep-22-26ReiteratedRobert W. Baird$85 → $90
Sep-08-26ReiteratedStifel Nicolaus$96 → $115
Aug-05-26ReiteratedCanaccord GenuityBuy$100 → $105
Aug-05-26ReiteratedStifel Nicolaus$90 → $96
Aug-05-26ReiteratedEvercore ISI GroupOutperform$45 → $105
Aug-05-26ReiteratedBarclaysOverweight$97 → $100
Aug-05-26ReiteratedRBC CapitalOutperform$75 → $110
Latest News· Times ET
Oct-29-26
Oct-26-26
Oct-16-26
Oct-12-26
Oct-08-26
Oct-06-26
Oct-05-26
Oct-01-26
Sep-30-26
Sep-28-26
Sep-24-26
Sep-23-26
Sep-22-26
Company

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
Total Revenue720588390293
Cost of Goods Sold Incl. D&A1121199099
Gross Profit608469301194
Selling, General and Administrative Excl. Other384639228215
Research and Development129368101110
Other Operating Expense2940
Operating Income93-546-32-131
Interest Expense
0000
Unusual Expense
————
Non-Operating Income (Expense)17192122
Net Income Before Taxes110-527-11-109
Income Taxes2110
Consolidated Net Income109-528-12-108
Net Income From Continuing Operations109-528-12-108
Net Income109-528-12-108
EPS (Recurring)1.35-5.36-0.15-1.39
EPS (Basic, Before Extraordinaries)1.35-5.36-0.15-1.39
EPS (Diluted)1.29-5.19-0.15-1.39
EBITDA103-536-18-125
Other After Tax Adjustments
————
Stock Option Compensation Expense
————
Price To Earnings Ratio
88.62———
Price To Sales Ratio12.546.24——
Gross Margin84.4479.7677.1866.21
Operating Margin12.92-92.86-8.21-44.71
Net Margin15.14-89.80-3.08-36.86
Shares Outstanding79797878
Market Capitalization9,0313,670——
Operating Lease Expense
————
Insider Trading Volume
$129.76$101.90$74.03$46.17$18.31● Close Price0.00M47.96M95.92M143.88M191.84MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Budge JamesChief Financial OfficerOct 12 '26Sale103.1347,7204,921,578296,728Oct 13
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-FounderOct 12 '26Sale103.13200,00020,626,3710Oct 13
Perez Daniel AntonioCEO & Co-FounderOct 06 '26Sale100.204,100410,8110Oct 07
Pursley JamesPresidentSep 21 '26Sale94.1433,0003,106,504666,909Sep 23
Robinson ElliottDirectorSep 14 '26Sale0.00000Sep 16
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-FounderSep 14 '26Sale93.22150,00013,982,8100Sep 15
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-FounderSep 11 '26Sale88.97250,00022,242,0690Sep 14
Budge JamesChief Financial OfficerSep 10 '26Sale89.4555,5614,969,999349,062Sep 11
Perez Daniel AntonioCEO & Co-FounderSep 10 '26Sale89.45250,00022,361,64335,470Sep 11
Robinson ElliottDirectorSep 09 '26Sale0.00000Sep 11
Robinson ElliottDirectorSep 08 '26Sale0.00000Sep 09
Robinson ElliottDirectorSep 03 '26Sale0.00000Sep 04
Robinson ElliottDirectorAug 26 '26Sale0.00000Aug 27
Pursley JamesPresidentAug 21 '26Sale88.0533,0002,905,663706,235Aug 24
Leslie Kristina MDirectorAug 20 '26Sale88.231,200105,87630,387Aug 21
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.